Literature DB >> 11128701

Evaluation, differential diagnosis, and treatment of xerostomia.

T E Daniels1.   

Abstract

The salivary component of Sjögren's syndrome (SS) is defined as xerostomia (dry mouth). However, xerostomia is a common symptom associated with quantitative and qualitative changes in saliva, which are generally referred to as salivary hypofunction. This can be caused by various systemic diseases (including SS), anticholinergic effects of many drugs, psychological conditions, and physiological changes. Chronic salivary hypofunction is clinically significant because it can cause oral dysfunction, dental destruction, and mucosal infection. Evaluating patients complaining of xerostomia requires particular attention to their current medications and physical examination of the major salivary glands, teeth, and oral mucosa. Based on that information and the differential diagnosis of salivary hypofunction, appropriate tests can then be selected to develop a final diagnosis. Effective treatment of patients with chronic salivary hypofunction requires a combination of: (1) ongoing dental decay prevention and treatment supervised by their dentist; (2) salivary flow stimulation; (3) recognition and treatment of chronic oral candidiasis; (4) selective use of saliva substitutes; and (5) prescription drug review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128701

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  7 in total

Review 1.  Thirst in critically ill patients: from physiology to sensation.

Authors:  Shoshana Arai; Nancy Stotts; Kathleen Puntillo
Journal:  Am J Crit Care       Date:  2013-07       Impact factor: 2.228

2.  Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics.

Authors:  Driss Zoukhri; Ian Rawe; Mabi Singh; Ashley Brown; Claire L Kublin; Kevin Dawson; William F Haddon; Earl L White; Kathleen M Hanley; Daniel Tusé; Wasyl Malyj; Athena Papas
Journal:  J Oral Sci       Date:  2012-03       Impact factor: 1.630

Review 3.  Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites.

Authors:  Antoon J M Ligtenberg; Niclas G Karlsson; Enno C I Veerman
Journal:  Int J Mol Sci       Date:  2010-12-17       Impact factor: 5.923

Review 4.  Xerostomia due to systemic disease: a review of 20 conditions and mechanisms.

Authors:  H Mortazavi; M Baharvand; A Movahhedian; M Mohammadi; A Khodadoustan
Journal:  Ann Med Health Sci Res       Date:  2014-07

5.  Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial.

Authors:  Cheng-Han Wu; Song-Chou Hsieh; Kuang-Lun Lee; Ko-Jen Li; Ming-Chi Lu; Chia-Li Yu
Journal:  J Formos Med Assoc       Date:  2006-10       Impact factor: 3.282

Review 6.  Compliance with Saliva Collection Protocol in Healthy Volunteers: Strategies for Managing Risk and Errors.

Authors:  Kashi Raj Bhattarai; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738

7.  Evaluation of the concordance of sialometry and salivary glands scintigraphy in dry mouth patients.

Authors:  Bianca Maria Liquidato; Rita de Cássia Soler; Ivo Bussoloti Filho
Journal:  Braz J Otorhinolaryngol       Date:  2006 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.